161 related articles for article (PubMed ID: 26381542)
1. Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression.
Malaponte G; Hafsi S; Polesel J; Castellano G; Spessotto P; Guarneri C; Canevari S; Signorelli SS; McCubrey JA; Libra M
Biochim Biophys Acta; 2016 Mar; 1863(3):483-489. PubMed ID: 26381542
[TBL] [Abstract][Full Text] [Related]
2. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Liu H; Chen A; Guo F; Yuan L
Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
[TBL] [Abstract][Full Text] [Related]
3. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
Castellano G; Malaponte G; Mazzarino MC; Figini M; Marchese F; Gangemi P; Travali S; Stivala F; Canevari S; Libra M
Clin Cancer Res; 2008 Nov; 14(22):7470-80. PubMed ID: 19010864
[TBL] [Abstract][Full Text] [Related]
4. [Effect of short-hairpin RNA expression vector-mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC-3 cells].
Liu H; Chen AM; Guo FJ; Liao H; Hu WH; Xie J
Chin J Cancer; 2010 Jan; 29(1):43-51. PubMed ID: 20038310
[TBL] [Abstract][Full Text] [Related]
5. MMP-9-cleaved osteopontin isoform mediates tumor immune escape by inducing expansion of myeloid-derived suppressor cells.
Shao L; Zhang B; Wang L; Wu L; Kan Q; Fan K
Biochem Biophys Res Commun; 2017 Dec; 493(4):1478-1484. PubMed ID: 28986261
[TBL] [Abstract][Full Text] [Related]
6. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
7. Recombinant osteopontin attenuates hyperoxia-induced acute lung injury through inhibiting nuclear factor kappa B and matrix metalloproteinases 2 and 9.
Zhang X; Liu F; Zhu G; Wang Z
Chin Med J (Engl); 2014; 127(23):4025-30. PubMed ID: 25430443
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin regulates growth and migration of human nasopharyngeal cancer cells.
Yang G; Zhang Y; Wu J; Xiong J; Deng H; Wang J; Yang C; Zhu Z
Mol Med Rep; 2011; 4(6):1169-73. PubMed ID: 21785824
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
Chen RX; Xia YH; Xue TC; Ye SL
Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
[TBL] [Abstract][Full Text] [Related]
10. [Study on the function of osteopontin in hyperoxia-induced acute lung injury and its mechanism].
Zhang XF; Foda HD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):385-9. PubMed ID: 17045020
[TBL] [Abstract][Full Text] [Related]
11. Influence of osteopontin short hairpin RNA on the proliferation and invasion of human renal cancer cells.
Liu H; Chen A; Guo F; Yuan L
J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):61-8. PubMed ID: 20155457
[TBL] [Abstract][Full Text] [Related]
12. Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-α therapy.
Buommino E; De Filippis A; Gaudiello F; Balato A; Balato N; Tufano MA; Ayala F
Arch Dermatol Res; 2012 Aug; 304(6):481-5. PubMed ID: 22684781
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion.
Philip S; Bulbule A; Kundu GC
Glycoconj J; 2004; 21(8-9):429-41. PubMed ID: 15750784
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
[TBL] [Abstract][Full Text] [Related]
15. Interrelationship of Osteopontin, MMP-9 and ADAMTS4 in Patients With Osteoarthritis Undergoing Total Joint Arthroplasty.
Slovacek H; Khanna R; Poredos P; Jezovnik M; Hoppensteadt D; Fareed J; Hopkinson W
Clin Appl Thromb Hemost; 2020; 26():1076029620964864. PubMed ID: 33350314
[TBL] [Abstract][Full Text] [Related]
16. NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
Guarneri C; Bevelacqua V; Polesel J; Falzone L; Cannavò PS; Spandidos DA; Malaponte G; Libra M
Oncol Rep; 2017 Feb; 37(2):737-746. PubMed ID: 28075446
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
[TBL] [Abstract][Full Text] [Related]
18. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
[TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin.
Liu J; Ren Y; Kang L; Zhang L
Int J Mol Med; 2014 May; 33(5):1341-7. PubMed ID: 24590381
[TBL] [Abstract][Full Text] [Related]
20. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Georges R; Adwan H; Zhivkova M; Eyol E; Bergmann F; Berger MR
Int J Oncol; 2010 Aug; 37(2):249-56. PubMed ID: 20596651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
